DK1301526T3 - Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre - Google Patents

Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre

Info

Publication number
DK1301526T3
DK1301526T3 DK01949791T DK01949791T DK1301526T3 DK 1301526 T3 DK1301526 T3 DK 1301526T3 DK 01949791 T DK01949791 T DK 01949791T DK 01949791 T DK01949791 T DK 01949791T DK 1301526 T3 DK1301526 T3 DK 1301526T3
Authority
DK
Denmark
Prior art keywords
alpha
beta
oxidation
9alpha
androst
Prior art date
Application number
DK01949791T
Other languages
Danish (da)
English (en)
Inventor
Frederick David Albinson
Steven John Coote
John Malcolm Robinson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1301526T3 publication Critical patent/DK1301526T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK01949791T 2000-07-21 2001-07-20 Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre DK1301526T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017988.7A GB0017988D0 (en) 2000-07-21 2000-07-21 Novel process
PCT/GB2001/003289 WO2002008243A1 (fr) 2000-07-21 2001-07-20 Procede d'oxydation pour la preparation de l'intermediaire acide 6 alpha, 9 alpha-difluoro-11 beta,17 alpha-dihydroxy-16.alpha-methyl-androst-1,4-dien-3-one 17 beta-carboxylique

Publications (1)

Publication Number Publication Date
DK1301526T3 true DK1301526T3 (da) 2008-10-06

Family

ID=9896132

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01949791T DK1301526T3 (da) 2000-07-21 2001-07-20 Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre

Country Status (26)

Country Link
US (1) US20040043974A1 (fr)
EP (1) EP1301526B1 (fr)
JP (1) JP2004504403A (fr)
KR (1) KR100787293B1 (fr)
CN (1) CN1315864C (fr)
AT (1) ATE398628T1 (fr)
AU (2) AU7090601A (fr)
BR (1) BR0110430A (fr)
CA (1) CA2406963A1 (fr)
CY (1) CY1108553T1 (fr)
CZ (1) CZ302592B6 (fr)
DE (1) DE60134472D1 (fr)
DK (1) DK1301526T3 (fr)
ES (1) ES2307628T3 (fr)
GB (1) GB0017988D0 (fr)
HK (1) HK1056179B (fr)
HU (1) HUP0301108A3 (fr)
IL (2) IL152348A0 (fr)
MX (1) MXPA02010967A (fr)
NO (1) NO324836B1 (fr)
NZ (1) NZ522083A (fr)
PL (1) PL206652B1 (fr)
PT (1) PT1301526E (fr)
SI (1) SI1301526T1 (fr)
WO (1) WO2002008243A1 (fr)
ZA (1) ZA200208372B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
IL150654A (en) 2002-07-09 2006-12-10 Ori Lerman Method for acid isolation 6α, 9α - difluoro - ß, 17α11 - dihydroxy - 16α - methylfargana - 3 - oxo - 1, 4 - diene - 17ß - carboxylate
CA2530680A1 (fr) * 2003-04-04 2004-10-14 Alpharma Aps Methode de preparation de derives et d'intermediaires d'acides carbothioiques steroides
EP1466920A1 (fr) * 2003-04-04 2004-10-13 Alpharma APS Procédé pour la préparation de stéroides 17-beta-carbothiates
EP1526139A1 (fr) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. Procédé pour la préparation d'acides 17-beta-carboxyliques d'androstane et d'esters fluorométhylés de l'acide 17-beta-carboxylique d'androstane de haute pureté
GB0612027D0 (en) 2006-06-16 2006-07-26 Glaxo Group Ltd Novel process
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
EP2611821A2 (fr) 2010-09-01 2013-07-10 Cadila Healthcare Limited Procédé pour préparer du fluticasone propionate/furoate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636010A (en) * 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
US4263289A (en) * 1978-04-05 1981-04-21 Syntex (U.S.A.) Inc. Thio etianic acid derivatives
US4198336A (en) * 1978-04-05 1980-04-15 Syntex (U.S.A.) Inc. Chemical process for preparing androsta-4-ene 17α-carboxylic acids
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
US5646136A (en) * 1994-01-04 1997-07-08 Duke University Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids
TR199801247T2 (xx) * 1995-12-29 1998-11-23 Glaxo Group Limited 17.beta.-karboksi, karbotio t�revleri ve amid androstan t�revleri.
US20020133032A1 (en) * 2000-02-25 2002-09-19 Jufang Barkalow Method for the preparation of fluticasone and related 17beta-carbothioic esters using a novel carbothioic acid synthesis and novel purification methods
KR100631256B1 (ko) * 2000-04-04 2006-10-02 셀라니즈 인터내셔날 코포레이션 아민 작용기로 그래프트된 폴리(비닐 알콜)을 함유하는잉크 수용성 피복 조성물
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions

Also Published As

Publication number Publication date
PT1301526E (pt) 2008-09-09
AU2001270906B2 (en) 2005-10-13
WO2002008243A1 (fr) 2002-01-31
PL206652B1 (pl) 2010-09-30
ZA200208372B (en) 2004-02-11
SI1301526T1 (sl) 2008-10-31
NZ522083A (en) 2004-06-25
ATE398628T1 (de) 2008-07-15
CZ302592B6 (cs) 2011-07-27
JP2004504403A (ja) 2004-02-12
CN1437610A (zh) 2003-08-20
AU7090601A (en) 2002-02-05
KR100787293B1 (ko) 2007-12-20
MXPA02010967A (es) 2003-03-27
NO324836B1 (no) 2007-12-17
ES2307628T3 (es) 2008-12-01
CN1315864C (zh) 2007-05-16
PL359462A1 (en) 2004-08-23
BR0110430A (pt) 2003-07-08
US20040043974A1 (en) 2004-03-04
KR20030028736A (ko) 2003-04-10
HK1056179B (zh) 2009-07-17
IL152348A (en) 2008-08-07
EP1301526B1 (fr) 2008-06-18
NO20025054L (no) 2002-11-05
HUP0301108A2 (hu) 2003-08-28
CY1108553T1 (el) 2014-04-09
HUP0301108A3 (en) 2008-04-28
HK1056179A1 (en) 2004-02-06
CA2406963A1 (fr) 2002-01-31
IL152348A0 (en) 2003-05-29
NO20025054D0 (no) 2002-10-21
DE60134472D1 (de) 2008-07-31
CZ20023472A3 (cs) 2003-04-16
EP1301526A1 (fr) 2003-04-16
GB0017988D0 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
DK1301526T3 (da) Fremgangsmåde til oxidation til fremstilling af mellemproduktet 6.alpha.,9alpha.-difluor-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-on 17.beta-carboxylsyre
DE69512797D1 (en) Prostaglandin-synthase hemmer
MXPA03007853A (es) Metodo para la sintesis de 2',3'-didesoxi-2',3'-dideshidronucleosidos.
DE69932864D1 (de) Neue Fettsäureanaloge zur Behandlung des Bluthochdrucks
ATE359272T1 (de) Verfahren zur herstellung von 3-hydroxy-n-1,6-
MXPA04000847A (es) Procedimiento para la obtencion de beraprost y sus sales.
NO20023276D0 (no) Fremgangsmåte til å fremstille betulinsyre
ATE457972T1 (de) Verfahren zur herstellung von 7-amino-syn-3,5- dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
DE60105441D1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
FI960301A (fi) Nikkelitön hemoglobiini ja menetelmät sellaisen hemoglobiinin tuottamiseksi
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
ATE302749T1 (de) Verfahren zur herstellung von 5-aminosalicylsäure
EA200300400A1 (ru) 17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
SE0201938D0 (sv) New process
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ZA200005110B (en) Process for preparing intermediates.
ATE277914T1 (de) Verfahren zur herstellung von 1,4,7,10- tetraazacyclododecan
DE60014103D1 (de) Verfahren zur herstellung von debromohymenialdisin und deren analogen
AU7851201A (en) Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
ATE309226T1 (de) Verfahren zur herstellung von fluconazole und kristallmodifikationen davon
ATE274519T1 (de) Verfahren zur herstellung von gehinderten phosphiten
UA32065A (uk) Спосіб підготовки води
HU0001287D0 (en) New intermediate and process for its production
DK1163257T3 (da) Fremgangsmåde til fremstilling af 4,4-dimethyl-3beta-hydroxypregna-8,14-dien-21-carboxylsyreestere og mellemprodukter i fremgangsmåden